BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7753986)

  • 1. Impact of stereotaxic core breast biopsy on cost of diagnosis.
    Liberman L; Fahs MC; Dershaw DD; Bonaccio E; Abramson AF; Cohen MA; Hann LE
    Radiology; 1995 Jun; 195(3):633-7. PubMed ID: 7753986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
    Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
    Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
    Hillner BE; Bear HD; Fajardo LL
    Acad Radiol; 1996 Apr; 3(4):351-60. PubMed ID: 8796686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of Core Biopsy for BI-RADS-5 Breast Lesions.
    Wolf R; Quan G; Calhoun K; Soot L; Skokan L
    Breast J; 2008; 14(5):471-5. PubMed ID: 18821933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US-guided core breast biopsy: use and cost-effectiveness.
    Liberman L; Feng TL; Dershaw DD; Morris EA; Abramson AF
    Radiology; 1998 Sep; 208(3):717-23. PubMed ID: 9722851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of stereotactic vacuum-assisted biopsy for nonpalpable breast lesions.
    Tsai HY; Huang ST; Chao MF; Kan JY; Hsu JS; Hou MF; Chiu HC
    Eur J Radiol; 2020 Jun; 127():108982. PubMed ID: 32334370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed?
    Liberman L; Dershaw DD; Rosen PP; Abramson AF; Deutch BM; Hann LE
    Radiology; 1994 Sep; 192(3):793-5. PubMed ID: 8058949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
    Groenewoud JH; Pijnappel RM; van den Akker-Van Marle ME; Birnie E; Buijs-van der Woude T; Mali WP; de Koning HJ; Buskens E
    Br J Cancer; 2004 Jan; 90(2):383-92. PubMed ID: 14735181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of stereotactic breast biopsy.
    Bernstein JR
    Semin Surg Oncol; 1996; 12(5):290-9. PubMed ID: 8873316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer.
    Lind DS; Minter R; Steinbach B; Abbitt P; Lanier L; Haigh L; Vauthey JN; Russin M; Hackett R; Copeland EM
    J Surg Res; 1998 Jul; 78(1):23-6. PubMed ID: 9733612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of stereotactic biopsy in assessment of nonpalpable breast lesions.
    Wallace JE; Sayler C; McDowell NG; Moseley HS
    Am J Surg; 1996 May; 171(5):471-3. PubMed ID: 8651387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years.
    Luparia A; Durando M; Campanino P; Regini E; Lucarelli D; Talenti A; Mattone G; Mariscotti G; Sapino A; Gandini G
    Radiol Med; 2011 Apr; 116(3):477-88. PubMed ID: 21225359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy.
    Liberman L; Sama MP
    AJR Am J Roentgenol; 2000 Jul; 175(1):53-8. PubMed ID: 10882245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in the diagnosis of nonpalpable breast lesions].
    Yoshimoto M; Tada T; Kasumi F
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):343-6. PubMed ID: 8709935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotaxic needle core biopsy of breast lesions using a regular mammographic table with an adaptable stereotaxic device.
    Caines JS; McPhee MD; Konok GP; Wright BA
    AJR Am J Roentgenol; 1994 Aug; 163(2):317-21. PubMed ID: 8037022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stereotactic 11-g vacuum-assisted breast biopsy on cost of diagnosis in Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2011 Jan; 77(1):131-6. PubMed ID: 19853395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nonpalpable solid breast masses with stereotaxic large-needle core biopsy using a dedicated unit.
    Meyer JE; Christian RL; Lester SC; Frenna TH; Denison CM; DiPiro PJ; Polger M
    AJR Am J Roentgenol; 1996 Jul; 167(1):179-82. PubMed ID: 8659367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpalpable breast tumors: diagnosis with stereotaxic localization and fine-needle aspiration.
    Dowlatshahi K; Gent HJ; Schmidt R; Jokich PM; Bibbo M; Sprenger E
    Radiology; 1989 Feb; 170(2):427-33. PubMed ID: 2643141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy.
    Yim JH; Barton P; Weber B; Radford D; Levy J; Monsees B; Flanagan F; Norton JA; Doherty GM
    Ann Surg; 1996 Jun; 223(6):688-97; discussion 697-700. PubMed ID: 8645042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.